Spartan Bioscience
LuminUltra Technologies Acquires Genomadix Legionella Testing Business
New Brunswick, Canada-based LuminUltra also acquired the rights to develop additional assays on Genomadix's MDx system.
Genomadix Gets FDA 510(k) Clearance for PCR System, CYP2C19 Test
Canada's Genomadix, formerly known as Spartan Bioscience, expects to now commercialize the system and test in the US to guide therapy decisions.
Genomadix, Mayo Clinic Collaborate on Point-of-Care PCR
The deal is intended to advance the firm's portable PCR-based diagnostics system, called the Cube, which generates results in approximately one hour.
Canada's Spartan Bioscience Reemerges as Genomadix With Eye Toward Near-Patient COVID-19 Testing
Premium
The firm is now moving forward on COVID-19 molecular diagnostic clinical trials in the US with the hopes of obtaining FDA Emergency Use Authorization.
Spartan Bioscience to Sell Assets to Finance Firm Casa-Dea
Casa-Dea said that it aims to keep Spartan in Canada following the close of the transaction, which is expected later this month.
Jan 28, 2020
Jul 27, 2016
Mar 18, 2015
Canon USA Invests in Spartan Bioscience
Sep 3, 2014
May 27, 2014
Aug 29, 2013
Feb 28, 2013